115 related articles for article (PubMed ID: 26965851)
41. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
[TBL] [Abstract][Full Text] [Related]
42. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.
Wållberg-Jonsson S; Cvetkovic JT; Sundqvist KG; Lefvert AK; Rantapää-Dahlqvist S
J Rheumatol; 2002 May; 29(5):875-82. PubMed ID: 12022343
[TBL] [Abstract][Full Text] [Related]
43. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
Tsimikas S; Lau HK; Han KR; Shortal B; Miller ER; Segev A; Curtiss LK; Witztum JL; Strauss BH
Circulation; 2004 Jun; 109(25):3164-70. PubMed ID: 15184281
[TBL] [Abstract][Full Text] [Related]
44. Relationships between serum levels of autoantibodies against oxidized low density lipoproteins, lipid-soluble antioxidants and apolipoprotein B in patients with coronary heart disease.
Bakalova RA; Hadzhimitova V; Ribarov S
Gen Physiol Biophys; 2000 Mar; 19(1):103-13. PubMed ID: 10930142
[TBL] [Abstract][Full Text] [Related]
45. Autoantibodies against oxidized low-density lipoprotein and C-reactive protein are associated with diabetes and myocardial infarction in women.
Dotevall A; Hulthe J; Rosengren A; Wiklund O; Wilhelmsen L
Clin Sci (Lond); 2001 Nov; 101(5):523-31. PubMed ID: 11672458
[TBL] [Abstract][Full Text] [Related]
46. Innate immune activity in plaque of patients with untreated and L-thyroxine-treated subclinical hypothyroidism.
Marfella R; Ferraraccio F; Rizzo MR; Portoghese M; Barbieri M; Basilio C; Nersita R; Siniscalchi LI; Sasso FC; Ambrosino I; Siniscalchi M; Maresca L; Sardu C; Amato G; Paolisso G; Carella C
J Clin Endocrinol Metab; 2011 Apr; 96(4):1015-20. PubMed ID: 21239513
[TBL] [Abstract][Full Text] [Related]
47. Autoantibodies Against ApoB-100 as a New Marker of Coronary Vulnerable Plaque.
Egusa G
J Atheroscler Thromb; 2021 Oct; 28(10):1020-1022. PubMed ID: 33455997
[No Abstract] [Full Text] [Related]
48. Carbamyl adducts on low-density lipoprotein induce IgG response in LDLR-/- mice and bind plasma autoantibodies in humans under enhanced carbamylation.
Kummu O; Turunen SP; Wang C; Lehtimäki J; Veneskoski M; Kastarinen H; Koivula MK; Risteli J; Kesäniemi YA; Hörkkö S
Antioxid Redox Signal; 2013 Oct; 19(10):1047-62. PubMed ID: 23311771
[TBL] [Abstract][Full Text] [Related]
49. Lymphocytes in atherosclerosis.
Wigren M; Nilsson J; Kolbus D
Clin Chim Acta; 2012 Oct; 413(19-20):1562-8. PubMed ID: 22565046
[TBL] [Abstract][Full Text] [Related]
50. Connective tissue growth factor is associated with a stable atherosclerotic plaque phenotype and is involved in plaque stabilization after stroke.
Leeuwis JW; Nguyen TQ; Theunissen MG; Peeters W; Goldschmeding R; Pasterkamp G; Vink A
Stroke; 2010 Dec; 41(12):2979-81. PubMed ID: 20966418
[TBL] [Abstract][Full Text] [Related]
51. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.
Santos AO; Fonseca FA; Fischer SM; Monteiro CM; Brandão SA; Póvoa RM; Bombig MT; Carvalho AC; Monteiro AM; Ramos E; Gidlund M; Figueiredo Neto AM; Izar MC
Clin Chim Acta; 2009 Aug; 406(1-2):113-8. PubMed ID: 19523463
[TBL] [Abstract][Full Text] [Related]
52. Statin treatment is not associated with consistent alterations in inflammatory status of carotid atherosclerotic plaques: a retrospective study in 378 patients undergoing carotid endarterectomy.
Verhoeven BA; Moll FL; Koekkoek JA; van der Wal AC; de Kleijn DP; de Vries JP; Verheijen JH; Velema E; Busser E; Schoneveld A; Virmani R; Pasterkamp G
Stroke; 2006 Aug; 37(8):2054-60. PubMed ID: 16809559
[TBL] [Abstract][Full Text] [Related]
53. Altered expression of inflammation-related genes in human carotid atherosclerotic plaques.
Di Taranto MD; Morgante A; Bracale UM; D'Armiento FP; Porcellini M; Bracale G; Fortunato G; Salvatore F
Atherosclerosis; 2012 Jan; 220(1):93-101. PubMed ID: 22112851
[TBL] [Abstract][Full Text] [Related]
54. Carotid Plaque Morphology Is Significantly Associated With Sex, Age, and History of Neurological Symptoms.
Wendorff C; Wendorff H; Pelisek J; Tsantilas P; Zimmermann A; Zernecke A; Kuehnl A; Eckstein HH
Stroke; 2015 Nov; 46(11):3213-9. PubMed ID: 26451032
[TBL] [Abstract][Full Text] [Related]
55. High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation.
Choudhury RP; Rong JX; Trogan E; Elmalem VI; Dansky HM; Breslow JL; Witztum JL; Fallon JT; Fisher EA
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1904-9. PubMed ID: 15319266
[TBL] [Abstract][Full Text] [Related]
56. Adipocyte fatty acid binding protein in atherosclerotic plaques is associated with local vulnerability and is predictive for the occurrence of adverse cardiovascular events.
Peeters W; de Kleijn DP; Vink A; van de Weg S; Schoneveld AH; Sze SK; van der Spek PJ; de Vries JP; Moll FL; Pasterkamp G
Eur Heart J; 2011 Jul; 32(14):1758-68. PubMed ID: 21059735
[TBL] [Abstract][Full Text] [Related]
57. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
[TBL] [Abstract][Full Text] [Related]
58. Autoantibody against, malondialdehyde-modified low density lipoprotein in patients with non-diabetic unstable angina: a potential role in immunologic reaction of plaque instability.
Kwon KH; Kwon HM; Hong BK; Kim DS; Lee JY; Ryu SK; Park BE; Park HY; Kim JH; Yoon YW; Cho SY; Kim HS
Yonsei Med J; 2002 Apr; 43(2):203-10. PubMed ID: 11971214
[TBL] [Abstract][Full Text] [Related]
59. Circulating malondialdehyde-modified low-density lipoprotein levels are associated with the presence of thin-cap fibroatheromas determined by optical coherence tomography in coronary artery disease.
Matsuo Y; Kubo T; Okumoto Y; Ishibashi K; Komukai K; Tanimoto T; Ino Y; Kitabata H; Hirata K; Imanishi T; Akagi H; Akasaka T
Eur Heart J Cardiovasc Imaging; 2013 Jan; 14(1):43-50. PubMed ID: 22573905
[TBL] [Abstract][Full Text] [Related]
60. Antibodies to malondialdehyde oxidized low-density lipoproteins predict long term cardiovascular mortality in high risk patients.
Maiolino G; Pedon L; Cesari M; Frigo AC; Barisa M; Rossitto G; Seccia TM; Zanchetta M; Rossi GP
Int J Cardiol; 2013 Sep; 168(1):484-9. PubMed ID: 23102599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
